Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Applications of Immunogenomics to Cancer
X. Shirley Liu, Elaine R. Mardis
Cell (2017) Vol. 168, Iss. 4, pp. 600-612
Open Access | Times Cited: 198

Showing 1-25 of 198 citing articles:

Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates
Yannick Simoni, Étienne Becht, Michael Fehlings, et al.
Nature (2018) Vol. 557, Iss. 7706, pp. 575-579
Closed Access | Times Cited: 1140
Advances in immunotherapy for hepatocellular carcinoma
Bruno Sangro, Pablo Sarobe, Sandra Hervás‐Stubbs, et al.
Nature Reviews Gastroenterology & Hepatology (2021) Vol. 18, Iss. 8, pp. 525-543
Open Access | Times Cited: 938
Personalized vaccines for cancer immunotherapy
Uǧur Şahin, Özlem Türeci
Science (2018) Vol. 359, Iss. 6382, pp. 1355-1360
Open Access | Times Cited: 920
Tumour evolution in hepatocellular carcinoma
Amanda J. Craig, Johann von Felden, Teresa García‐Lezana, et al.
Nature Reviews Gastroenterology & Hepatology (2019) Vol. 17, Iss. 3, pp. 139-152
Closed Access | Times Cited: 681
Neoantigens: promising targets for cancer therapy
Na Xie, Guobo Shen, Wei Gao, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 468
Role of Immunotherapy in Triple-Negative Breast Cancer
Tanya E. Keenan, Sara M. Tolaney
Journal of the National Comprehensive Cancer Network (2020) Vol. 18, Iss. 4, pp. 479-489
Open Access | Times Cited: 452
Genomic correlates of response to immune checkpoint blockade
Tanya E. Keenan, Kelly P. Burke, Eliezer M. Van Allen
Nature Medicine (2019) Vol. 25, Iss. 3, pp. 389-402
Open Access | Times Cited: 413
A nanovaccine for antigen self-presentation and immunosuppression reversal as a personalized cancer immunotherapy strategy
Chao Liu, Xue Liu, Xinchu Xiang, et al.
Nature Nanotechnology (2022) Vol. 17, Iss. 5, pp. 531-540
Open Access | Times Cited: 238
pVACtools: A Computational Toolkit to Identify and Visualize Cancer Neoantigens
Jasreet Hundal, Susanna Kiwala, Joshua F. McMichael, et al.
Cancer Immunology Research (2020) Vol. 8, Iss. 3, pp. 409-420
Open Access | Times Cited: 193
Computational Strategies for Dissecting the High-Dimensional Complexity of Adaptive Immune Repertoires
Enkelejda Miho, Alexander Yermanos, Cédric R. Weber, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 185
Best practices for bioinformatic characterization of neoantigens for clinical utility
Megan M. Richters, Huiming Xia, Katie M. Campbell, et al.
Genome Medicine (2019) Vol. 11, Iss. 1
Open Access | Times Cited: 176
Triple-negative breast cancer: promising prognostic biomarkers currently in development
Jasmine Sukumar, Kelly C. Gast, Dionisia Quiroga, et al.
Expert Review of Anticancer Therapy (2020) Vol. 21, Iss. 2, pp. 135-148
Open Access | Times Cited: 159
Landscape of B cell immunity and related immune evasion in human cancers
Xihao Hu, Jian Zhang, Jin Wang, et al.
Nature Genetics (2019) Vol. 51, Iss. 3, pp. 560-567
Open Access | Times Cited: 148
Advancing precision medicine: the transformative role of artificial intelligence in immunogenomics, radiomics, and pathomics for biomarker discovery and immunotherapy optimization
Luchen Chang, Jiamei Liu, Jialin Zhu, et al.
Cancer Biology and Medicine (2025), pp. 1-15
Open Access | Times Cited: 4
Adaptive Immune Receptor Repertoire Community recommendations for sharing immune-repertoire sequencing data
Florian Rubelt, Christian E. Busse, Syed Ahmad Chan Bukhari, et al.
Nature Immunology (2017) Vol. 18, Iss. 12, pp. 1274-1278
Open Access | Times Cited: 159
Systematically benchmarking peptide-MHC binding predictors: From synthetic to naturally processed epitopes
Weilong Zhao, Xinwei Sher
PLoS Computational Biology (2018) Vol. 14, Iss. 11, pp. e1006457-e1006457
Open Access | Times Cited: 150
High-Throughput Prediction of MHC Class I and II Neoantigens with MHCnuggets
Xiaoshan M. Shao, Rohit Bhattacharya, Justin Huang, et al.
Cancer Immunology Research (2019) Vol. 8, Iss. 3, pp. 396-408
Open Access | Times Cited: 138
Challenges and strategies for next-generation bispecific antibody-based antitumor therapeutics
Heliang Li, Phei Er Saw, Erwei Song
Cellular and Molecular Immunology (2020) Vol. 17, Iss. 5, pp. 451-461
Open Access | Times Cited: 137
Breast cancer genomics and immuno-oncological markers to guide immune therapies
Dora Hammerl, Marcel Smid, A. Mieke Timmermans, et al.
Seminars in Cancer Biology (2017) Vol. 52, pp. 178-188
Open Access | Times Cited: 136
Discovery of coding regions in the human genome by integrated proteogenomics analysis workflow
Yafeng Zhu, Lukas M. Orre, Henrik J. Johansson, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 135
Precision oncology in the age of integrative genomics
Chandan Kumar‐Sinha, Arul M. Chinnaiyan
Nature Biotechnology (2018) Vol. 36, Iss. 1, pp. 46-60
Open Access | Times Cited: 134
Common, intermediate and well‐documented HLA alleles in world populations: CIWD version 3.0.0
Carolyn Katovich Hurley, Jane Kempenich, Kim Wadsworth, et al.
HLA (2020) Vol. 95, Iss. 6, pp. 516-531
Open Access | Times Cited: 123
Recent updates in cancer immunotherapy: a comprehensive review and perspective of the 2018 China Cancer Immunotherapy Workshop in Beijing
Zihai Li, Wenru Song, Mark P. Rubinstein, et al.
Journal of Hematology & Oncology (2018) Vol. 11, Iss. 1
Open Access | Times Cited: 109
Multiplexed activation of endogenous genes by CRISPRa elicits potent antitumor immunity
Guangchuan Wang, Ryan D. Chow, Zhigang Bai, et al.
Nature Immunology (2019) Vol. 20, Iss. 11, pp. 1494-1505
Open Access | Times Cited: 99
Insights Into Lung Cancer Immune-Based Biology, Prevention, and Treatment
Sara Saab, Hussein Zalzale, Zahraa Rahal, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 99
Page 1 - Next Page

Scroll to top